Houston, TX USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Two MD Anderson Faculty Named as Prestigious AAAS Fellows


Distinguished contributions to understanding p53 tumor suppression in stem cells and breakthrough advances in treating breast cancer have earned two scientists at The University of Texas MD Anderson Cancer Center membership in a notable association...
23-Nov-2015 11:00 AM EST Add to Favorites

Tumor-Suppressor p53 Regulates Protein That Stifles Immune Attack on Cancer


A crucial tumor-thwarting gene protects an immune attack against lung cancer by blocking the key to an off switch on T cells, the customized warriors of the immune system, a team led by researchers at The University of Texas MD Anderson Cancer...
20-Nov-2015 10:05 AM EST Add to Favorites

MD Anderson Receives $22.2 Million in CPRIT Research Funding

The University of Texas MD Anderson Cancer Center was awarded more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas (CPRIT).
20-Nov-2015 9:05 AM EST Add to Favorites

ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences


Codiak BioSciences, Inc. announced today the closing of the first portion of a planned $80-plus million Series A and B financing. The company also executed license and sponsored research agreements with The University of Texas MD Anderson Cancer...
17-Nov-2015 6:00 AM EST Add to Favorites

New York Businessman, Philanthropist Gives $30 Million to Cancer Research


Andy Sabin, of East Hampton, N.Y., has committed $30 million — the philanthropist’s largest grant to date — to support research at The University of Texas MD Anderson Cancer Center.
17-Nov-2015 1:05 AM EST Add to Favorites

Research Points to Why Some Colorectal Cancers Recur After Treatment


Cetuximab, marketed as Erbitux®, is one of the key therapies for metastatic colorectal cancer. Yet the cancer still returns in some patients, shortening overall survival.
16-Nov-2015 4:00 PM EST Add to Favorites

Study Reveals Why Chemotherapy May Be Compromised in Patients with Pancreatic Cancer


A study at The University of Texas MD Anderson Cancer Center may explain why chemotherapy drugs such as gemcitabine are not effective for many pancreatic cancer patients, and perhaps point to new approaches to treatment including enhancing ...
11-Nov-2015 1:00 PM EST Add to Favorites

Dallas a Conversation with a Living Legend® to Honor Dr. Condoleezza Rice


Former Secretary of State Condoleezza Rice is the honoree of A Conversation With a Living Legend®, benefiting The University of Texas MD Anderson Cancer Center, Tuesday Dec. 1 at the Hilton Anatole in Dallas.
9-Nov-2015 1:05 PM EST Add to Favorites

Our Experts on Newswise

MD Anderson Study Reveals New Insight Into Tumor Progression


Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6


A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System


The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

MD Anderson Energy Balance Expert Available for Obesity, Cancer Stories

30-Oct-2013 8:10 PM EDT

MD Anderson Obesity and Cancer Expert Researches Food Addiction

30-Oct-2013 8:00 PM EDT

The HPV Vaccine: What Have We Learned?

Expert at The University of Texas M. D. Anderson Cancer Center provide insight to parents based on what we've learned about about the HPV vaccine in the past four years.
12-Jan-2010 3:45 PM EST

M. D. Anderson Offers Guidance on Choosing Tobacco Cessation Products

Whether you smoke three cigarettes or three packs of cigarettes a day, kicking the habit is difficult. Various nicotine replacement products are on the market to make quitting easier. But which product is right for you? Experts from The University...
11-Nov-2009 4:15 PM EST

Our YouTube Videos